Autoimmune Diagnostics Leadership Initiative
Autoimmune Diseases
CommercialActive
Key Facts
About Vibrant America Clinical Laboratory
Vibrant America is a commercial-stage clinical laboratory specializing in high-volume, automated diagnostic testing. It has positioned itself as a cost-effective provider with a rapidly expanding test menu, notably gaining FDA Emergency Use Authorization for COVID-19 serum and dried blood spot tests and achieving New York State accreditation. The company's strategy centers on technological innovation in multiplex testing and automation to drive down costs and improve turnaround times, aiming to become a leader in the autoimmune diagnostics segment while serving a national client base.
View full company profileTherapeutic Areas
Other Autoimmune Diseases Drugs
| Drug | Company | Phase |
|---|---|---|
| Humira (Adalimumab) Biosimilar | NeuClone | Early Preclinical |
| HBM7020 | Harbour BioMed | Discovery |
| R2006 | Harbour BioMed | Discovery |
| R7027 | Harbour BioMed | Discovery |
| ImmCelz™ Platform | Creative Medical Technology Holdings | Preclinical |
| Not specified in provided content | 3Sbio | Various |
| Gavocabtagene autoleucel | astellas | Phase 1/2 |
| TYK-101 | TYK Medicines | Phase 1 |
| HCB206 | HanchorBio | Preclinical |
| miR-124 Activator | Formation Bio | Phase 2 |
| Autologous Cell Therapy Collaboration | Lupagen | Preclinical |
| I&I Portfolio | Third Arc Bio | Pre-clinical |